Inflammation as prognostic hallmark of clinical outcome in patients with SARS-CoV-2 infection

D Fuzio, AM Inchingolo, V Ruggieri, M Fasano… - Life, 2023 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is often characterized by a
life-threatening interstitial pneumonia requiring hospitalization. The aim of this retrospective …

IL-6 and other biomarkers associated with poor prognosis in a cohort of hospitalized patients with COVID-19 in Madrid

E Donoso-Navarro, I Arribas Gómez… - Biomarker …, 2021 - journals.sagepub.com
Objectives: There are several published works on the prognostic value of biomarkers in
relation to the severity or fatal outcome of coronavirus disease 2019 (COVID-19). In Spain …

Systemic inflammatory predictors of in-hospital mortality in COVID-19 patients: a retrospective study

B Kudlinski, D Zgoła, M Stolińska, M Murkos, J Kania… - Diagnostics, 2022 - mdpi.com
The purpose of this study was to investigate whether routine blood tests and clinical
characteristics can predict in-hospital mortality in COVID-19. Clinical data of 285 patients …

Validation of predictors of disease severity and outcomes in COVID-19 patients: a descriptive and retrospective study

L Tan, X Kang, X Ji, G Li, Q Wang, Y Li, Q Wang… - Med, 2020 - cell.com
Background The severity and outcome of COVID-19 cases has been associated with the
percentage of circulating lymphocytes (LYM%), levels of C-reactive protein (CRP) …

Interleukin-6 and C-reactive protein on admission as predictor of mortality in severe COVID-19 patients: A retrospective cohort study

R Rahayu, W Winarto, T Nasihun - Open Access Macedonian Journal of …, 2022 - oamjms.eu
Predictors of mortality, an important factor to guide management in COVID-19 patients, have
not been fully understood. The common laboratory test for assessing severity in COVID-19 …

Cytokines and their relationship with the severity and prognosis of coronavirus disease 2019 (COVID-19): a retrospective cohort study

QQ Liu, A Cheng, Y Wang, H Li, L Hu, X Zhao… - BMJ open, 2020 - bmjopen.bmj.com
Objective To delineate the characteristics and clinical significance of plasma inflammatory
cytokines altered in COVID-19. Design Retrospective, single-centre cohort study. Setting …

[HTML][HTML] Association of inflammatory markers with mortality in COVID-19 infection

AR Arshad, I Khan, K Shahzad, M Arshad, SJ Haider… - Age (years), 2020 - jcpsp.pk
Objective: To evaluate the association of serum ferritin, lactate dehydrogenase, and C-
reactive protein at admission with in-hospital mortality in COVID-19 infection; and to …

[HTML][HTML] Increased inflammatory mediators levels are associated with clinical outcomes and prolonged illness in severe COVID-19 patients

W Hao, M Liu, C Bai, X Liu, S Niu, X Chen - International …, 2023 - Elsevier
Objective The purpose of this study was to identify potential predictors of clinical outcome in
severe COVID-19 patients and to investigate the relationship between immunological …

[HTML][HTML] Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19

W Sayah, I Berkane, I Guermache, M Sabri, FZ Lakhal… - Cytokine, 2021 - Elsevier
Accumulating evidence supports that the viral-induced hyper-inflammatory immune
response plays a central role in COVID-19 pathogenesis. It might be involved in the …

Evaluation of hematological changes and immune response biomarkers as a prognostic factor in critical patients with COVID-19

LRA Manaças, RLO Amorim, A Aguila, PC Novo… - Plos one, 2024 - journals.plos.org
COVID-19 disease has been a challenge for health systems worldwide due to its high
transmissibility, morbidity, and mortality. Severe COVID-19 is associated with an imbalance …